[Hiring] Interventional Business Manager @Glaukos

Role Description

As an Interventional Business Manager (iBM), you will play a pivotal role in driving the adoption and integration of advanced ophthalmic technologies within clinical practices. You’ll collaborate with surgeons and practice teams to expand patient access, provide clinical and business support, and ensure successful implementation of innovative solutions. This role blends strategic sales execution with education and customer partnership to improve patient outcomes and grow market presence.

What Impact Will I Make?

As an Interventional Business Manager (iBM), you will help shape the future of eye care by serving as a trusted advisor to surgeons and their staff, driving territory growth by:

• Building strong relationships
• Delivering product expertise
• Helping practices successfully integrate new therapies for better patient outcomes

What Will I Do?

• Sales Strategy & Execution
  • Consistently achieve monthly, quarterly, and annual sales goals across multiple product lines.
  • Develop and execute business plans to expand market share and maximize territory performance.
  • Identify, cultivate, and convert new business opportunities while maintaining and growing existing relationships.
• Customer Engagement & Education
  • Build and maintain strong partnerships with ophthalmic surgeons, staff, and key healthcare stakeholders.
  • Provide clinical and product education to help practices identify eligible patients and integrate new technologies.
  • Deliver impactful training and support to ensure a positive customer and patient experience.
• Market Development & Event Participation
  • Represent the company at targeted industry conferences, meetings, and educational programs to generate leads and build brand visibility.
  • Organize and facilitate local peer-to-peer and training events that support surgeon engagement.
  • Monitor market trends and competitive activities to inform territory strategy and protect market position.

Qualifications

• Bachelor’s degree required; MBA or other advanced business or healthcare-related degree preferred.
• 5 plus years of medical sales experience, including at least 3 years in surgical ophthalmology (ophthalmic pharmaceutical experience preferred).
• Demonstrated success in launching new products, expanding territories, and exceeding sales goals.
• Proven ability to build strong relationships and collaborate across all levels within practices and organizations.
• Skilled in consultative, value-based selling with the ability to translate complex clinical concepts clearly.
• Strong communication, presentation, and analytical abilities; proficiency with Microsoft Office and CRM tools (Salesforce preferred).
• Highly organized with strong business acumen and the ability to manage budgets and expenses effectively.
• Curious, proactive, and strategic — driven to understand customer needs and deliver tailored solutions.
• Committed to ethical conduct, compliance, and professional excellence in all aspects of the role.

Requirements

• Total Targeted Cash Compensation: $270K plus RSU's

Company Description

Founded in 1998, Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.

• Our mission at Glaukos is to truly transform vision by pioneering novel, dropless therapies that can meaningfully advance the standard of care and improve the lives of patients suffering from chronic, sight-threatening eye diseases.
• Innovation is at the core of everything we do, and we are resolute in our commitment to challenge conventional thinking with new treatment alternatives that are supported by real science, robust clinical evidence, and an unrelenting focus on patients.
• Our constant pursuit of game-changing technologies that disrupt legacy treatment paradigms is encapsulated in the Glaukos mantra “We’ll Go First.”
• Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol “GKOS.”
• Our global headquarters is in Aliso Viejo, California with additional locations in San Clemente, California, and Burlington, Massachusetts.